Polyethylene Glycol 3350-GRX Powder 100% jars a) 8.4 oz (250 g) (NDC 54162-335-02), b) Net wt. 1...
FDA Drug Recall #D-0393-2016 — Class II — October 27, 2015
Recall Summary
| Recall Number | D-0393-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 27, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Geritrex Corp |
| Location | Mount Vernon, NY |
| Product Type | Drugs |
| Quantity | 3,796 jars (8.4 oz) 3,204, (16.9 oz) 3,350 |
Product Description
Polyethylene Glycol 3350-GRX Powder 100% jars a) 8.4 oz (250 g) (NDC 54162-335-02), b) Net wt. 16.9 oz (500 g) (NDC 54162-335-05), Distributed by: Geritrex Corporation, Mount Vernon, NY 10550
Reason for Recall
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Distribution Pattern
Nationwide
Lot / Code Information
Lot #: a) 1201092, 1403053, 1210028, 1007059, 1112105, 1305044, 1303079, 1406098, 1407061, 1505037, 1412004 1408081, b) 1112105 & 1007036
Other Recalls from Geritrex Corp
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0392-2016 | Class II | GRx HiCort 25 (hydrocortisone acetate 25 mg) Su... | Oct 27, 2015 |
| D-0390-2016 | Class II | Carbo-O-Philic 40 Cream 40% (Urea) tubes, a) 3 ... | Oct 27, 2015 |
| D-0391-2016 | Class II | Carbo-O-Philic 40 Gel 40% (Urea) NET WT tube, .... | Oct 27, 2015 |
| D-1238-2015 | Class III | Carb-O-Philic 40 Cream, 40%, a) 3 oz. tube (NDC... | Jun 5, 2015 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.